[Pathologic morphology of cervical carcinoma with endolymphatic infusion of immuno-modulating drugs].
Prior to standard therapy, an immunomodulator was administered by endolymphic infusion to 85 patients with cervical carcinoma (T3NxMo), with a view to reinforce treatment. The drug was fed to lymph collectors which were regional and aregional with respect to tumor. Also, the treatment was supplemented with regional infusion of considerable doses of cytostatic mixes. Our morphological evidence pointed to the stimulation of cytostatic effect by immunomodulation.
Rozenko
L Ia
LIa
Research Institute of Oncology, Ministry of Health of the RF, Rostov-on-Don.
Nepomniashchaia
E M
EM
Rubtsov
V R
VR
Gudtskova
T N
TN
Tartanova
T M
TM
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic; D008875:Middle Aged; D009367:Neoplasm Staging; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000473:pathology*
D000276:Adjuvants, Immunologic